individuals within the three identified social groups interact significantly more than expected by chance ( Figure 2 ).
Even in this most recent study, the fundamental issue of how subjectivity in defining behavior can be avoided remains. For example, the mathematical definition of what exactly constitutes an interaction between two ants has to be chosen subjectively, and different definitions of interaction are likely to produce different networks and thus different pictures of the social structure. It would, therefore, be useful to evaluate the impact of alternative definitions of behavior on how the data are interpreted. The ultimate goal, however, should be to score and quantify behavior without any preconceived notion of what constitutes a relevant behavior. For instance, by performing a principal component analysis on the shape of C. elegans worms extracted from short movies, Stephens et al. [19] showed that 95% of the observed variance in the worms' shape could be described with only four dimensions. This interesting result could be extended to the more complex case of individuals interacting within a group. By simultaneously measuring many parameters using setups like the one described by Mersch et al. [1] , it might be possible to obtain high dimensional measurements for each individual and interaction, and to extract the most significant behavioral patterns through dimensionality-reduction schemes. 
Mitophagy: Mitofusin Recruits a Mitochondrial Killer
Parkin is a cytosolic ubiquitin ligase that translocates to damaged mitochondria and promotes their degradation. Recent work demonstrates that a phosphorylated form of the mitochondrial fusion protein Mitofusin 2 serves as a receptor for Parkin translocation to damaged mitochondria.
Leo Pallanck
After more than two billion years, the intimate relationship between mitochondria and the eukaryotic cell remains an imperfect union. Although mitochondria play essential cellular roles, they can harm or kill cells when they become damaged, and the accumulation of damaged mitochondria is implicated in aging and in common diseases of the elderly. Fortunately, eukaryotes have evolved multiple cellular pathways to prevent and repair mitochondrial damage, and, in extreme circumstances, to discard extensively damaged mitochondria altogether [1] . The machinery involved in detection and removal of entire damaged mitochondria was identified only recently through studies of the PINK1 and parkin genes, mutations of which cause Parkinson's disease. Genetic studies in the fruit fly Drosophila demonstrated that PINK1 acts upstream from Parkin to regulate mitochondrial morphology and integrity, and led to the hypothesis that PINK1 and Parkin promote the fragmentation and degradation of damaged mitochondria [2] . More recently, cell biological studies provided direct support for a role of PINK1 and Parkin in the degradation of damaged mitochondria, and began to elucidate the mechanisms by which they do so. This body of work has led to the model that PINK1, a mitochondrially targeted serine/threonine kinase, selectively accumulates on the surface of depolarized mitochondria, where it recruits Parkin, a ubiquitin-protein ligase. Parkin then ubiquitinates mitochondrial outer membrane proteins, including the mitochondrial fusion protein mitofusin and the mitochondrial trafficking factor Miro, to promote the isolation and lysosomal degradation of these damaged mitochondria through a process termed mitophagy (reviewed in [3] ). Among the many unanswered questions related to the PINK1-Parkinmediated mitophagy pathway is how PINK1 accumulation on the mitochondrial surface leads to the recruitment of Parkin. Recent work by Yun Chen and Gerald Dorn [4] now offers an answer to this question -in heart cells, at least. In previously published work, these investigators found that heart-specific double knockouts of mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) in mice resulted in the accumulation of damaged and fragmented mitochondria [5] . These dysfunctional mitochondria should be ideal targets of PINK1-Parkinmediated mitophagy, so their accumulation was unexpected. Moreover, there was no reason to think that mitofusin deficiency should impair PINK1-Parkin-mediated mitophagy, given that previous work indicated that mitofusins are normally degraded by the PINK1-Parkin pathway to prevent damaged mitochondria from fusing with healthy ones [6] . These surprising findings led Chen and Dorn to test whether mitofusins played a more active role in mitophagy. The investigators discovered that treatment of Mfn1-deficient cardiomyocytes with mitochondrial depolarizing agents resulted in the expected recruitment of Parkin to these mitochondria. However, Mfn2-deficient cardiomyocytes showed no Parkin recruitment after mitochondrial depolarization. Further studies demonstrated that Parkin bound to Mfn2, but not to Mfn1, and that the binding of Parkin to Mfn2 was enhanced by overexpression of PINK1. Together, these findings indicate that Mfn2 is a PINK1-stimulated receptor for Parkin recruitment to depolarized mitochondria.
Given that PINK1 is a kinase, the obvious question was whether PINK1 stimulates Mfn2 to recruit Parkin by directly phosphorylating Mfn2. Chen and Dorn [4] found that co-expression of PINK1 and Mfn2 resulted in the appearance of a more slowly migrating Mfn2 species upon gel electrophoresis analysis, and that the formation of this Mfn2 species was dependent on the PINK1 kinase activity. Subsequent studies confirmed that the slowly migrating species represented a phosphorylated form of Mfn2, and ultimately led to the identification of two residues in Mfn2, Thr111 and Ser442, that are phosphorylated by PINK1. Mutation of either Thr111 or Ser442 to alanine reduced Parkin binding to Mfn2, and mutating both sites to alanine completely eliminated Parkin binding to Mfn2. By contrast, mutating both sites to glutamate, thus mimicking the phosphorylated state, stimulated Parkin binding to Mfn2 in a PINK1-independent fashion. These findings led to the model that PINK1 accumulation on the surface of damaged mitochondria results in the phosphorylation of Mfn2, the recruitment of Parkin to phosphorylated Mfn2, and ultimately the Parkin-stimulated degradation of the damaged mitochondria in the lysosome.
The findings of Chen and Dorn [4] represent a significant advance in our understanding of the PINK1-Parkin pathway, but also raise questions. One of the most important questions raised by these new findings is whether Mfn2 is the only mitochondrial Parkin receptor. Previously published work using mouse embryonic fibroblasts from Mfn1/Mfn2 null animals demonstrated normal Parkin recruitment to depolarized mitochondria [7] . These findings suggest the existence of multiple Parkin receptors that function in a tissue-specific fashion and/or function redundantly with one another. Along these same lines, recent work has shown that the voltage-dependent anion channel proteins (VDACs 1, 2, and 3) act as redundant mitochondrial Parkin receptors in vertebrate cell culture [8] . The mitochondrial outer membrane protein Miro is also a direct substrate of PINK1 and Parkin [9] , and previous work suggests that there may be many more outer membrane substrates of the PINK1-Parkin pathway (e.g. [10, 11] ): these additional substrates might also serve as Parkin receptors. Finally, work from Richard Youle's laboratory has shown that misdirecting PINK1 to peroxisomes or lysosomes is sufficient to trigger Parkin recruitment to these compartments, thus challenging the notion of a specific Parkin receptor acting downstream from PINK1 [12] .
Another question that arises from the work of Chen and Dorn [4] is whether the cardiac phenotypes of Mfn1/Mfn2 double knockouts, or Mfn2 single knockouts reflect a specific defect in mitophagy. Because cardiac ablation of Mfn2 in mice and null mutations of parkin in Drosophila cause similar progressive dilated cardiomyopathy phenotypes, Chen and Dorn suggest that a failure of Parkin-mediated mitophagy contributed to the cardiomyopathy in Mfn2-deficient mice. However, this model must be reconciled with the finding that parkin knockout mice do not exhibit cardiomyopathy [13] . One possible explanation for these discordant findings is that the organ-specific Mfn2 knockout animals may lack a developmental compensation that appears to at least partially explain the mild phenotypes of whole-animal Parkin deficiency [14] . Alternatively, the more severe phenotypes of the Mfn2 knockout animals may reflect the many cellular roles that Mfn2 is believed to play. In addition to serving as a Parkin receptor for mitophagy, mitofusins have been shown to influence mitochondrial metabolism, apoptosis, and tethering of mitochondria to the endoplasmic reticulum [15] , and Mfn2 ablation in the heart causes endoplasmic reticulum stress and impaired autophagosome-lysosome fusion [16] . Thus, the phenotypes of the Mfn2 knockout animals could involve perturbations of any of these pathways. Further study will be required to define the mechanisms underlying the progressive cardiomyopathy in Mfn2 knockout mice.
Finally, perhaps the most important question arising from the work of Chen and Dorn [4] concerns the exact function of Parkin recruitment by Mfn2. Surely the purpose of Parkin recruitment cannot be simply to degrade Mfn2; otherwise Mfn2-deficient cardiomyocytes would not have a mitophagy defect. An intriguing potential explanation is that Parkin binding to phosphorylated Mfn2 could trigger the localized activation of Parkin at the mitochondrial surface. This hypothesis is supported by the finding that Parkin's ubiquitin ligase activity is stimulated upon localization to mitochondria [17] , and by recent work suggesting that Parkin requires conformational changes to become catalytically active [18] . Parkin activation could involve a conformational change triggered by binding to phosphorylated Mfn2 ( Figure 1A) . Alternatively, because previous work has shown that Parkin itself can be a substrate of PINK1 (e.g. [19] ), binding of Parkin to phosphorylated Mfn2 may simply position Parkin near PINK1, so that PINK1 can phosphorylate and thereby activate Parkin ( Figure 1B) . Activation of Parkin on the mitochondrial surface could enable it to indiscriminately ubiquitinate mitochondrial proteins in a highly localized fashion. This model potentially offers an explanation for why Mfn2 is a degradation target of Parkin and yet is also required for Parkin-stimulated mitophagy.
There has been rapid progress in deciphering the mechanisms by which damaged mitochondria are detected and degraded since PINK1 and Parkin were implicated in this process, and the work of Chen and Dorn [4] represents yet another important piece of this puzzle. While their findings raise a number of new questions, this is to be expected of all groundbreaking studies. Importantly, all of the questions raised by the new work are readily testable, so the answers to these questions may be forthcoming soon. 
